Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.

Masuda S, Lemaitre F, Barten MJ, Bergan S, Shipkova M, van Gelder T, Vinks S, Wieland E, Bornemann-Kolatzki K, Brunet M, de Winter B, Dieterlen MT, Elens L, Ito T, Johnson-Davis K, Kunicki PK, Lawson R, Lloberas N, Marquet P, Millan O, Mizuno T, Moes DJAR, Noceti O, Oellerich M, Pattanaik S, Pawinski T, Seger C, van Schaik R, Venkataramanan R, Walson P, Woillard JB, Langman LJ

Open source

DOI: 10.1097/ftd.0000000000001250
Published: 2025 Feb 1
Container: Therapeutic drug monitoring
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/ftd.0000000000001250,
  title = {Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.},
  author = {Masuda S and Lemaitre F and Barten MJ and Bergan S and Shipkova M and van Gelder T and Vinks S and Wieland E and Bornemann-Kolatzki K and Brunet M and de Winter B and Dieterlen MT and Elens L and Ito T and Johnson-Davis K and Kunicki PK and Lawson R and Lloberas N and Marquet P and Millan O and Mizuno T and Moes DJAR and Noceti O and Oellerich M and Pattanaik S and Pawinski T and Seger C and van Schaik R and Venkataramanan R and Walson P and Woillard JB and Langman LJ},
  year = {2025},
  journal = {Therapeutic drug monitoring},
  doi = {10.1097/ftd.0000000000001250},
  url = {https://doi.org/10.1097/ftd.0000000000001250}
}

RIS

TY  - JOUR
TI  - Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
AU  - Masuda S
AU  - Lemaitre F
AU  - Barten MJ
AU  - Bergan S
AU  - Shipkova M
AU  - van Gelder T
AU  - Vinks S
AU  - Wieland E
AU  - Bornemann-Kolatzki K
AU  - Brunet M
AU  - de Winter B
AU  - Dieterlen MT
AU  - Elens L
AU  - Ito T
AU  - Johnson-Davis K
AU  - Kunicki PK
AU  - Lawson R
AU  - Lloberas N
AU  - Marquet P
AU  - Millan O
AU  - Mizuno T
AU  - Moes DJAR
AU  - Noceti O
AU  - Oellerich M
AU  - Pattanaik S
AU  - Pawinski T
AU  - Seger C
AU  - van Schaik R
AU  - Venkataramanan R
AU  - Walson P
AU  - Woillard JB
AU  - Langman LJ
PY  - 2025
JO  - Therapeutic drug monitoring
DO  - 10.1097/ftd.0000000000001250
UR  - https://doi.org/10.1097/ftd.0000000000001250
ER  -

APA

S, M., F, L., MJ, B., S, B., M, S., T, V. G., S, V., E, W., K, B., M, B., B, D. W., MT, D., L, E., T, I., K, J., PK, K., R, L., N, L., P, M., O, M., T, M., DJAR, M., O, N., M, O., S, P., T, P., C, S., R, V. S., R, V., P, W., JB, W., & LJ, L. (2025). Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.. Therapeutic drug monitoring. https://doi.org/10.1097/ftd.0000000000001250

Source records

pubmed · retrieved 2026-09-26T05:04:14.633Z